Study Outcomes Among Patients with Parkinson’s Disease Treated for Psychosis Residing in the Long-Term Care Setting and Newly Initiating Pimavanserin or Off-Label Atypical Antipsychotics

IntroductionPsychosis is a common feature of Parkinson’s Disease (PD), with an estimated 50% of PD patients experiencing psychosis (i.e., hallucinations [H] or delusions [D]) at some time during the course of their illness. Pimavanserin (PIM) is the only medication approved in the US for the treatme...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	CNS spectrums 2023-04, Vol.28 (2), p.253-253
Hauptverfasser:	Meyers, Juliana, Nham, Tram, Wang, Stanley, Esterberg, Lizzi, Rashid, Nazia
Format:	Artikel
Sprache:	eng
Schlagworte:	Abstracts Antipsychotics Long term health care Parkinson's disease Patients Psychosis Psychotropic drugs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!